| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |